BackExpreS2ion Biotech Holding AB (publ) Overview

ExpreS2ion Biotech Holding AB (publ) Goodwill

Track ExpreS2ion Biotech Holding AB (publ)'s goodwill ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

ExpreS2ion Biotech Holding AB (publ) Goodwill History

Loading

ExpreS2ion Biotech Holding AB (publ) vs. peers: Goodwill Comparison

Loading

ExpreS2ion Biotech Holding AB (publ) Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) FAQ

ExpreS2ion Biotech Holding AB (publ) posts a goodwill of $0 as of June 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, ExpreS2ion Biotech Holding AB (publ)'s goodwill was $0. The latest reading is $0 (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Goodwill is one piece of ExpreS2ion Biotech Holding AB (publ)'s financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for EXPRS2.ST's goodwill usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ExpreS2ion Biotech Holding AB (publ)'s other metric pages and overview cover the third.

Judging ExpreS2ion Biotech Holding AB (publ) against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in goodwill easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.